- Home
- KLTO vs TTNP Comparison
KLTO vs TTNP Comparison
Compare KLTO & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTO
- TTNP
- Stock Information
- Founded
- KLTO 2019
- TTNP 1991
- Country
- KLTO United States
- TTNP United States
- Employees
- KLTO N/A
- TTNP N/A
- Industry
- KLTO
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KLTO
- TTNP Health Care
- Exchange
- KLTO NYSE
- TTNP Nasdaq
- Market Cap
- KLTO 5.9M
- TTNP 5.9M
- IPO Year
- KLTO N/A
- TTNP 1996
- Fundamental
- Price
- KLTO $1.34
- TTNP $4.37
- Analyst Decision
- KLTO
- TTNP
- Analyst Count
- KLTO 0
- TTNP 0
- Target Price
- KLTO N/A
- TTNP N/A
- AVG Volume (30 Days)
- KLTO 22.5M
- TTNP 6.8K
- Earning Date
- KLTO 08-15-2025
- TTNP 08-14-2025
- Dividend Yield
- KLTO N/A
- TTNP N/A
- EPS Growth
- KLTO N/A
- TTNP N/A
- EPS
- KLTO N/A
- TTNP N/A
- Revenue
- KLTO N/A
- TTNP N/A
- Revenue This Year
- KLTO N/A
- TTNP N/A
- Revenue Next Year
- KLTO N/A
- TTNP N/A
- P/E Ratio
- KLTO N/A
- TTNP N/A
- Revenue Growth
- KLTO N/A
- TTNP N/A
- 52 Week Low
- KLTO $0.11
- TTNP $3.03
- 52 Week High
- KLTO $3.91
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- KLTO N/A
- TTNP 48.42
- Support Level
- KLTO N/A
- TTNP $4.12
- Resistance Level
- KLTO N/A
- TTNP $4.65
- Average True Range (ATR)
- KLTO 0.00
- TTNP 0.19
- MACD
- KLTO 0.00
- TTNP -0.00
- Stochastic Oscillator
- KLTO 0.00
- TTNP 46.40
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.